Gail Frances McIntyre

Insider Reports History

Location
C/O Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC
Signature
/s/ Abel Svitavsky, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gail Frances McIntyre:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aravive, Inc. CEO and President, Director Common stock 65.5K $60.2K $0.92 Oct 24, 2022 Direct
Aravive, Inc. CEO and President, Director Stock Option (Right to Buy) 700K Feb 1, 2023 Direct
Aravive, Inc. CEO and President, Director Series A Warrants (right to buy) 27.2K Oct 24, 2022 Direct
Aravive, Inc. CEO and President, Director Series B Warrants (right to buy) 27.2K Oct 24, 2022 Direct

Insider Reports Filed by Gail Frances McIntyre

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARAV Aravive, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 CEO and President, Director
ARAV Aravive, Inc. Oct 24, 2022 3 $50K 4 Oct 26, 2022 CEO and President, Director
ARAV Aravive, Inc. Jan 24, 2022 1 $0 4 Jan 25, 2022 CEO and President, Director
ARAV Aravive, Inc. Jun 29, 2021 1 $5.35K 4 Jun 29, 2021 CEO and President, Director